IRIS Accounts Production v23.1.5.20 10473166 director 1.4.22 31.3.23 31.3.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh104731662022-03-31104731662023-03-31104731662022-04-012023-03-31104731662021-03-31104731662021-04-012022-03-31104731662022-03-3110473166ns15:EnglandWales2022-04-012023-03-3110473166ns14:PoundSterling2022-04-012023-03-3110473166ns10:Director12022-04-012023-03-3110473166ns10:PrivateLimitedCompanyLtd2022-04-012023-03-3110473166ns10:SmallEntities2022-04-012023-03-3110473166ns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3110473166ns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3110473166ns10:SmallCompaniesRegimeForAccounts2022-04-012023-03-3110473166ns10:FullAccounts2022-04-012023-03-3110473166ns10:RegisteredOffice2022-04-012023-03-3110473166ns5:CurrentFinancialInstruments2023-03-3110473166ns5:CurrentFinancialInstruments2022-03-3110473166ns5:ShareCapital2023-03-3110473166ns5:ShareCapital2022-03-3110473166ns5:RetainedEarningsAccumulatedLosses2023-03-3110473166ns5:RetainedEarningsAccumulatedLosses2022-03-3110473166ns5:PlantMachinery2022-04-012023-03-3110473166ns5:PlantMachinery2022-03-3110473166ns5:PlantMachinery2023-03-3110473166ns5:PlantMachinery2022-03-3110473166ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3110473166ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-31104731661ns10:Director12022-03-31104731661ns10:Director12021-03-31104731661ns10:Director12022-04-012023-03-31104731661ns10:Director12021-04-012022-03-31104731661ns10:Director12023-03-31104731661ns10:Director12022-03-31
REGISTERED NUMBER: 10473166 (England and Wales)















Financial Statements for the Year Ended 31 March 2023

for

JTS Orthopaedic Consultancy Limited

JTS Orthopaedic Consultancy Limited (Registered number: 10473166)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


JTS Orthopaedic Consultancy Limited

Company Information
for the Year Ended 31 March 2023







DIRECTOR: J T Smith





REGISTERED OFFICE: Dane John Works
Gordon Road
Canterbury
Kent
CT1 3PP





REGISTERED NUMBER: 10473166 (England and Wales)





ACCOUNTANTS: A.K & Co (Accountancy Services) Ltd
19 Victoria Terrace
Hove
East Sussex
BN3 2WB

JTS Orthopaedic Consultancy Limited (Registered number: 10473166)

Balance Sheet
31 March 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 60,436 748

CURRENT ASSETS
Debtors 5 117,078 124,279
Cash at bank 242,563 68,368
359,641 192,647
CREDITORS
Amounts falling due within one year 6 78,766 69,259
NET CURRENT ASSETS 280,875 123,388
TOTAL ASSETS LESS CURRENT
LIABILITIES

341,311

124,136

PROVISIONS FOR LIABILITIES 11,483 142
NET ASSETS 329,828 123,994

CAPITAL AND RESERVES
Called up share capital 56 56
Retained earnings 329,772 123,938
SHAREHOLDERS' FUNDS 329,828 123,994

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 9 October 2023 and were signed by:





J T Smith - Director


JTS Orthopaedic Consultancy Limited (Registered number: 10473166)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

JTS Orthopaedic Consultancy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

JTS Orthopaedic Consultancy Limited (Registered number: 10473166)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2022 5,423
Additions 71,651
At 31 March 2023 77,074
DEPRECIATION
At 1 April 2022 4,675
Charge for year 11,963
At 31 March 2023 16,638
NET BOOK VALUE
At 31 March 2023 60,436
At 31 March 2022 748

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 73,119 60,042
Other debtors 43,959 64,237
117,078 124,279

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 76,765 67,334
Other creditors 2,001 1,925
78,766 69,259

7. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2023 and 31 March 2022:

2023 2022
£    £   
J T Smith
Balance outstanding at start of year 46,763 38,241
Amounts advanced 728 12,690
Amounts repaid (23,991 ) (4,168 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 23,500 46,763

8. ULTIMATE CONTROLLING PARTY

The controlling party is J T Smith.